Get started
ALK-ABELLO B A/SALK-ABELLO B A/SALK-ABELLO B A/S

ALK-ABELLO B A/S

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ALK_B chart


Full chart

ALK_B upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪35.71 B‬DKK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
51.4
Basic EPS (TTM)
3.1DKK
Net income (FY)
‪486.00 M‬DKK
Revenue (FY)
‪4.82 B‬DKK
Shares float
‪130.47 M‬
Beta (1Y)
0.57

Employees


Employees (FY)
‪2.82 K‬
Change (1Y)
+144 +5.37%
Revenue / Employee (1Y)
‪252.86 K‬DKK
Net income / Employee (1Y)
‪25.47 K‬DKK

About ALK-ABELLO B A/S


Sector
Health Technology
Industry
Biotechnology
CEO
Peter Halling
Website
alk.net
Headquarters
Hørsholm
Founded
1961
ISIN
DK0061802139
FIGI
BBG000FBNG52
ALK-Abello A/S engages in the production and development of pharmaceutical products to prevent and treat allergies. The firm manufactures tablet-based allergy vaccines for pollen, house dust mites, animals, and insect stings. Its treatment comprises allergy vaccines, emergency treatment, and allergy diagnostics. The company was founded by Poul Christian Krejner Tejn Barfod on June 9, 1923 and is headquartered in Horsholm, Denmark.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

ALK_B news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ALK_B is 163.6 DKK — it has increased by 2.00% in the past 24 hours. Watch ALK-ABELLO B A/S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXCOP exchange ALK-ABELLO B A/S stocks are traded under the ticker ALK_B.
ALK_B stock has fallen by −0.30% compared to the previous week, the month change is a −4.22% fall, over the last year ALK-ABELLO B A/S has showed a 113.58% increase.
We've gathered analysts' opinions on ALK-ABELLO B A/S future price: according to them, ALK_B price has a max estimate of 200.00 DKK and a min estimate of 150.00 DKK. Watch ALK_B chart and read a more detailed ALK-ABELLO B A/S stock forecast: see what analysts think of ALK-ABELLO B A/S and suggest that you do with its stocks.
ALK_B reached its all-time high on Aug 27, 2024 with the price of 185.6 DKK, and its all-time low was 13.3 DKK and was reached on Aug 9, 2011. View more price dynamics on ALK_B chart.
See other stocks reaching their highest and lowest prices.
ALK_B stock is 2.43% volatile and has beta coefficient of 0.57. Track ALK-ABELLO B A/S stock price on the chart and check out the list of the most volatile stocks — is ALK-ABELLO B A/S there?
Today ALK-ABELLO B A/S has the market capitalization of ‪35.50 B‬, it has decreased by −1.15% over the last week.
Yes, you can track ALK-ABELLO B A/S financials in yearly and quarterly reports right on TradingView.
ALK-ABELLO B A/S is going to release the next earnings report on Nov 14, 2024. Keep track of upcoming events with our Earnings Calendar.
ALK_B earnings for the last quarter are 0.90 DKK per share, whereas the estimation was 0.72 DKK resulting in a 24.14% surprise. The estimated earnings for the next quarter are 0.83 DKK per share. See more details about ALK-ABELLO B A/S earnings.
ALK-ABELLO B A/S revenue for the last quarter amounts to ‪1.37 B‬ DKK, despite the estimated figure of ‪1.31 B‬ DKK. In the next quarter, revenue is expected to reach ‪1.29 B‬ DKK.
ALK_B net income for the last quarter is ‪201.00 M‬ DKK, while the quarter before that showed ‪232.00 M‬ DKK of net income which accounts for −13.36% change. Track more ALK-ABELLO B A/S financial stats to get the full picture.
No, ALK_B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 2, 2024, the company has ‪2.82 K‬ employees. See our rating of the largest employees — is ALK-ABELLO B A/S on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALK-ABELLO B A/S EBITDA is ‪1.17 B‬ DKK, and current EBITDA margin is 18.84%. See more stats in ALK-ABELLO B A/S financial statements.
Like other stocks, ALK_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALK-ABELLO B A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALK-ABELLO B A/S technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALK-ABELLO B A/S stock shows the buy signal. See more of ALK-ABELLO B A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.